# High Flow Nasal Oxygen for Exacerbation COPD

> **NCT06084117** · NA · RECRUITING · sponsor: **Franciscus Gasthuis** · enrollment: 40 (estimated)

## Conditions studied

- Acute Exacerbation of COPD

## Interventions

- **OTHER:** HFNO
- **OTHER:** NIV

## Key facts

- **NCT ID:** NCT06084117
- **Lead sponsor:** Franciscus Gasthuis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-14
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06084117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06084117, "High Flow Nasal Oxygen for Exacerbation COPD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06084117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
